{"id":"interruption-of-oral-anticoagulants","safety":{"commonSideEffects":[{"rate":null,"effect":"Thromboembolism (stroke, DVT, PE)"},{"rate":null,"effect":"Bleeding complications"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Interruption of oral anticoagulants refers to a managed clinical intervention where anticoagulant therapy is deliberately paused, typically perioperatively or for specific clinical procedures. This is a therapeutic management strategy rather than a pharmacological agent, designed to balance bleeding risk during procedures against thrombotic risk from interrupted anticoagulation.","oneSentence":"This is a clinical protocol for temporarily stopping oral anticoagulant medications, not a drug itself.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:49:27.186Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Perioperative management of patients on chronic oral anticoagulation"},{"name":"Bridging strategy for patients requiring temporary cessation of anticoagulants"}]},"trialDetails":[{"nctId":"NCT07185295","phase":"PHASE4","title":"Short-term Interruption Versus Continuous Anticoagulation in Colorectal Polypectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Outcomes'10","startDate":"2024-10-18","conditions":"Anticoagulated Patients","enrollment":481},{"nctId":"NCT06887270","phase":"NA","title":"Peri-procedural Management of Direct Oral Anticoagulants for Central VENOus Catheters in CAncer Patients With Venous Thromboembolism or Atrial Fibrillation Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-09","conditions":"Anticoagulant-induced Bleeding, Direct Oral Anticoagulant, Cancer","enrollment":10},{"nctId":"NCT06844227","phase":"","title":"Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)","status":"RECRUITING","sponsor":"McMaster University","startDate":"2021-12-01","conditions":"Atrial Fibrillation (AF)","enrollment":1780},{"nctId":"NCT05378035","phase":"","title":"DOAC in Chinese Patients With Atrial Fibrillation","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2022-09-28","conditions":"Atrial Fibrillation, Stroke, Stroke, Acute","enrollment":427},{"nctId":"NCT04437303","phase":"PHASE4","title":"Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)","status":"COMPLETED","sponsor":"St. Antonius Hospital","startDate":"2020-11-25","conditions":"Aortic Valve Disease, Aortic Valve Stenosis, Stroke","enrollment":858},{"nctId":"NCT06216769","phase":"NA","title":"Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2024-02-01","conditions":"Atrial Fibrillation","enrollment":400},{"nctId":"NCT04195113","phase":"","title":"Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry","status":"COMPLETED","sponsor":"McMaster University","startDate":"2019-08-07","conditions":"Atrial Fibrillation, Venous Thromboembolism, Arterial Vascular Disease","enrollment":242},{"nctId":"NCT05486351","phase":"","title":"Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke","status":"UNKNOWN","sponsor":"Instituto de Investigación Hospital Universitario La Paz","startDate":"2021-03-05","conditions":"Cardioembolic Stroke, Anticoagulant Therapy, Stroke Recurrence","enrollment":318},{"nctId":"NCT03568916","phase":"","title":"Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs DOACs)","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2016-11","conditions":"Atrial Fibrillation, Ischemic Stroke, Systemic Embolization","enrollment":227579}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Interruption of oral anticoagulants","genericName":"Interruption of oral anticoagulants","companyName":"St. Antonius Hospital","companyId":"st-antonius-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a clinical protocol for temporarily stopping oral anticoagulant medications, not a drug itself. Used for Perioperative management of patients on chronic oral anticoagulation, Bridging strategy for patients requiring temporary cessation of anticoagulants.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}